Biotechnology VALUE FUND II L.P., 10% Owner at FIVE PRIME THERAPEUTICS, INC. (FPRX), bought 968,112 shares at $4.00 ($3.9M) on 2019-11-05, disclosed to the SEC on 2019-11-07.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.00 | 70,921 | $284K | 7.3% |
| 2 | $4.00 | 400,470 | $1.6M | 41.4% |
| 3 | $4.00 | 496,721 | $2.0M | 51.3% |
| Total | $4.00 avg | 968,112 | $3.9M | 100% |
| Filing → |
| THRD | BUY | 2022-12-22 | $1.7M | — | Filing → |
| KYMR | BUY | 2022-08-23 | $14.2M | — | Filing → |
| RPTX | BUY | 2022-06-15 | $3.8M | — | Filing → |